U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine

The FDA’s own label says that roughly one in 25 women who take abortion drugs will end up in the emergency room. Women can face excruciating pain, severe bleeding for weeks on end, and life-threatening infections, which is why the ongoing, in-person care of a doctor is critical.

No. This case has nothing to do with contraception or Plan B. This case is about making sure the FDA reinstates the safeguards it deemed necessary for women and girls who use the abortion drug mifepristone during the first trimester of their pregnancies. We are asking the Court to hold the FDA accountable for its reckless removal of critical safety standards around chemical abortion drugs.

Absolutely not. The FDA’s own labels warns that roughly one in 25 women who take abortion drugs will end up in the emergency room. That doesn’t happen from taking a Tylenol or Advil.

ADF has never relied on these studies for the issues that are currently before the Court. So the retractions will not have any effect on the Court’s consideration. Regardless, it was wrong for Sage to withdraw research that does not fit a preferred narrative and retract these articles without advancing a valid objection to the findings and no legitimate reason for these retractions.